Oncotarget

Research Papers:

Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model

Azam Salari, Kathrin Thomay, Jana Lentes, Juliane Ebersold, Maike Hagedorn, Britta Skawran, Claudia Davenport, Axel Schambach, Brigitte Schlegelberger and Gudrun Göhring _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:29869-29876. https://doi.org/10.18632/oncotarget.25581

Metrics: PDF 520 views  |   HTML 811 views  |   ?  


Abstract

Azam Salari1, Kathrin Thomay1, Jana Lentes1, Juliane Ebersold1, Maike Hagedorn1, Britta Skawran1, Claudia Davenport1, Axel Schambach2, Brigitte Schlegelberger1 and Gudrun Göhring1

1Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany

2Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany

Correspondence to:

Gudrun Göhring, email: Goehring.Gudrun@MH-Hannover.de

Keywords: TP53 mutation; hematopoietic stem cells (HSCs); haematopoiesis; erythropoiesis; MDS

Received: July 15, 2017     Accepted: May 19, 2018     Published: July 06, 2018

ABSTRACT

TP53 deficiencies characterize myeloid malignancies with a dismal prognosis. To unravel the pathomechanism of TP53 mutations in the development of myeloid malignancies, we analyzed the functional properties of TP53 conformational and contact mutations and TP53 loss in human CD34+ cells. We show for the first time that the analyzed conformational mutations lead to higher cell viability in human hematopoietic stem progenitor cells. In contrast to these conformational mutations, contact mutations interfered with efficient erythropoiesis.

These findings show that not only the detection of a TP53 mutation is important, but also the specific mutation may play a role in malignant transformation and progression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25581